In spite the role of SphK2 in colon cancer remains unclear, this isoform was shown to contribute to oxaliplatin resistance in human colon cancer cells [45], and its inhibition by sodium butyrate results in colon cancer cell apoptosis [50]. This evidence concerns the gene SPHK2 and colonic neoplasm.